The global health ecosystem is undergoing a tectonic shift: from youthful to aging populations, from stable to evolving regulatory landscapes, and from developed to developing markets. We team with companies across biopharmaceuticals, medical devices, distributors and pharmacies, payers and providers to address their strategic and operational issues. Our experts bring a forward-thinking, collaborative style that has proven to deliver immediate, meaningful solutions that last.
Health providers need to focus as much on influencing patients’ beliefs and behaviors as on treating their ailments.
BBC, 24 April 2014
Keith Lostaglio, A.T. Kearney partner, explains the impact of this multi-billion dollar deal on Asia and why the pharmaceutical giants may have chosen now to join forces.
Nutraceuticals represent one of the most exciting areas of health innovation, but achieving full potential will require all stakeholders to adapt.
Europe, Middle East, and Africa